Connect
MJA
MJA

An integrated and coordinated approach to preventing recurrent coronary heart disease events in Australia

Tom G Briffa, Leigh Kinsman, Andrew J Maiorana, Robert Zecchin, Julie Redfern, Patricia M Davidson, Glenn Paull, Amanda Nagle and A Robert Denniss
Med J Aust 2009; 190 (12): 683-686.
Published online: 15 June 2009

Coronary heart disease (CHD) is prevalent and costly.1 It has been estimated that implementing the existing evidence base for the treatment and management of patients with an acute coronary syndrome would reduce mortality by up to 80%.2 Cardiac rehabilitation (CR) and heart failure management (HFM) programs are widely acknowledged as effective secondary prevention interventions.3,4 Recent systematic reviews of these interventions reinforce the survival advantage of CR and HFM programs in the modern treatment and management of CHD.5-7 Importantly, these programs are safe and cost-effective compared with other treatment strategies,3,8 and are beneficial for patients of all ages.4 These programs lead to improved clinical and behavioural outcomes, including fewer hospital readmissions, better adherence to pharmacotherapy, enhanced functional status, improved risk profile, less depression, and better quality of life.4,9 However, they are widely underutilised, with fewer than one in three eligible patients attending CR4,10 and about one in 10 taking part in HFM programs.11 Additionally, those at highest risk for recurrent disease are least likely to participate in these programs.12 Moreover, the Australian Cardiovascular Health and Rehabilitation Association recommends that national health outcome data be collected to inform program effectiveness, policy and planning.

The aim of this review is to summarise the current evidence for CR and secondary prevention programs to stimulate practitioners, planners and policymakers to consider the way secondary prevention is practised, and to encourage development of services that meet the broad needs of Australians with cardiovascular disease (CVD).

Efficacy of cardiac rehabilitation

Since the 1980s, meta-analyses of traditional CR have shown a reduction in mortality of about 25%.3 These findings have been replicated and extended to cover secondary prevention programs in two contemporary systematic reviews of up to 63 randomised controlled trials (21 295 patients with coronary disease), which showed that supervised exercise alone5 or medical management without supervised exercise6 led to reductions in mortality. Further, patients with CVD who engage in secondary prevention initiatives have fewer non-fatal disease manifestations, including myocardial infarction, revascularisation therapy and rehospitalisation.4,7,9

CR has positive effects on biomedical and behavioural risk factors. Exercise training and education programs favourably modify lipid levels, blood pressure, insulin sensitivity and glucose homeostasis, weight, and smoking rates.6,9 Exercise programs are particularly effective at improving functional status and countering deconditioning in cardiac patients with13 or without heart failure.9 Many studies have shown that including counselling in CR programs improves quality of life and reduces depression.3,4,9

Models of effective secondary prevention and their core components

Since the 1960s, CR in Australia has been traditionally based on about 8 weeks of supervised group exercise and education.6,14 Recent advances in risk factor management, improved revascularisation techniques and earlier mobilisation have led to shorter hospital stays and reduced deconditioning.3,4 As a result, CR programs are evolving into flexible multifaceted preventive interventions to provide maximal clinical benefits to a majority of patients with a variety of conditions.15 Contemporary scientific evidence shows that effective secondary prevention is achieved through a range of different models in addition to traditional CR.6,15

Three models of care, consistently described and systematically evaluated in the literature, have been categorised as:

  • “education and counselling with an exercise component”;

  • “education and counselling without a supervised exercise component”; and

  • “exercise only”.6

Education and counselling with exercise programs tend to be short-term and are group-based with supervised exercise sessions. Programs providing education and counselling without supervised exercise are generally based on an individual intervention, are nurse-led, long-term and often include telephone support.6 Exercise-only programs focus on supervised sessions over the short term. Most contemporary CR programs in Australia are multidisciplinary, have an average duration of 7 weeks (SD, 3 weeks), are conducted in groups, and have educational and physical activity components (Box 1). Many of these programs accelerate resumption of daily activities, expedite role resumption, educate patients about symptom management, address psychological issues, and reinforce behaviours designed to stabilise or reverse the progression of the atherothrombotic process.14,16

Although there is strong evidence that CR and secondary prevention programs are beneficial, it is unclear from large, rigorous systematic reviews which model of care provides most benefit.5,6,9 Regardless of the program type, interventions are best initiated early after the diagnosis of CHD to educate patients about potential complications and initiate effective secondary prevention strategies.17 These programs vary in staffing, structure, content and length, according to available resources, referral patterns, patient preferences and capacity to implement evidence-based guidelines. Interestingly, a meta-regression concluded that short-term group programs in primary care were as effective in reducing all-cause mortality as longer hospital-based programs run by specialists.18 In contrast, HFM services provide individualised ongoing care by a specialised multidisciplinary team.7 Overall, current evidence suggests that a flexible model offering a range of services in a variety of settings is the most effective preventive intervention for people with CVD.

Over the past decade, more flexible models with durations ranging from 3 to 48 months focusing on individualised care have emerged, such as the Stanford Coronary Risk Intervention Project (SCRIP),19 a model for nursing case management (MULTIFIT),20 Coaching patients On Achieving Cardiovascular Health (COACH),21 the updated Heart Manual22 and the Choice of Health Options In prevention of Cardiovascular Events (CHOICE).23 Most of these effective longer-term secondary prevention programs involve:

  • coordinated ongoing care provided by a primary care physician;

  • a team of health care professionals;

  • building a patient–provider partnership;

  • episodic surveillance of biological and behavioural disease markers;

  • adherence to protective medications; and

  • an integrated menu of service provision catering for groups and individuals in a variety of settings (medical practice, community, hospital, residential), supplemented by educational resources reinforcing adherence to evidence-based therapies.

Together with flexible CR programs, these models expand the reach of service delivery and prevention of recurrent coronary events.

The core components of CR or secondary prevention programs should include intervention, evaluation, and a review of outcomes, including a quality improvement process.24 The intervention should be evidence-based, informed by national guidelines, and include individual goals and strategies that underpin long-term secondary prevention, and return to work if appropriate, and should incorporate exercise, education and psychosocial interventions.6,16 For evaluation, the key elements include a psychosocial appraisal, medication review, and medical and risk factor assessments as advised by national guidelines.16,25 Others suggest the addition of nutritional and physical activity assessments,15 automatic program referral and initial entry assessment within 4 weeks of the acute event, preferably earlier.17 For outcomes and quality improvement, programs should progress towards the individual’s preferred goals, assessment of needs, and identification of people at high risk, with targets and interventions being revised as required.24 Data about program use (proportion referred, attended and completed) and readmissions to hospital within 12 months should also be recorded.

Improving access to secondary prevention

Despite the proven benefits of CR and HFM programs, a minority of patients use them.10,11 Barriers relating to the availability of programs, referrals, attendance, completion and long-term maintenance have been extensively studied and are multifactorial.10,25-27 Examples include patients’ indifferent perceptions of such programs, failure of clinicians to refer patients, insufficient organisational support, lack of flexibility, distance from secondary prevention services, and fragmented funding. Several strategies have been recommended to facilitate the uptake of programs, including automatic referral processes, encouragement to attend by treating doctors, and flexible interventions in a variety of settings.15,18 The Australian Cardiovascular Health and Rehabilitation Association strongly recommends multifaceted strategies to promote effective flexible secondary prevention interventions at the local, state and national levels (Box 2). Such services should be tailored to the needs, preferences, cultural safety and circumstances of individual patients (and carers) while being appropriate for their clinical status. We also recommend that each CR and HFM program should, at a minimum, collect data on the numbers of patients referred, the proportion who enter and complete the intervention, and basic demographic information (age, sex, Indigenous status and diagnosis). Such national data would inform program use and quality improvement activities.

Heart failure and cardiac rehabilitation

Patients with heart failure often present with advanced cardiovascular symptoms, necessitating a specialist multidisciplinary service and appropriate risk stratification. Furthermore, the incidence of heart failure increases in the elderly, in whom comorbidities (eg, respiratory disease, renal impairment, diabetes, arthritis, depression) are more prevalent, necessitating additional medical resources. All patients with heart failure, including those with automated implantable devices, should be offered access to a facility-based or home-based, telephone-supported CR program. An estimated 25% of Australians with heart failure live in rural and remote regions, far from specialist HFM facilities, emphasising the need for non-facility-based programs and integration with primary care.11 Specialised multidisciplinary HFM programs also provide direct medical back-up and advanced therapy options, such as drug titration and inotrope therapy for acute exacerbations.7 In non-metropolitan regions, generic chronic disease programs involving staff trained in HFM should be adapted for continuing secondary prevention.28 Ideally, cardiovascular secondary prevention inpatient, outpatient and home-based care services should be seamlessly integrated to encourage cost-effective continuity of care.

The promotion of self-care is integral to HFM programs through symptom identification and management plans incorporating a flexible diuretic regimen, and discussion of polypharmacy and comorbidity (which increases the potential for haemodynamic compromise) to counter acute clinical deterioration.29 Individual or group counselling about prognosis, treatment options and treatment limitation in the event of clinical deterioration is important.28 Advanced care planning and referral to palliative care services may be appropriate for symptom management.28 Carers of patients with heart failure should be involved in the care process where possible. If transport is a barrier to attending facility-based CR programs, the availability of community transport should be explored, or home-based, telephone-supported disease management programs, such as COACH21 or the system of care used in the Chronic Heart failure Assisted by Telephone (CHAT) study, should be considered.30

Exercise training in heart failure

The evidence base for the efficacy of exercise training in patients with heart failure is stronger than that for rehabilitation for other cardiac conditions. A recent meta-analysis identified that exercise training is safe in patients whose condition is stable, and consistently increases functional capacity.13 Most of the benefit appears to be the result of peripheral adaptations,31 although modest improvements in cardiac function have also been reported.32 Regular physical activity and exercise is “strongly recommended” as an adjunct to pharmacological therapy for patients with heart failure, and is an essential component of comprehensive HFM.28 The benefits of strength training can also be useful in addressing deleterious effects of ageing.

Summary

CR and secondary prevention programs should be flexible, culturally appropriate, multifaceted and integrated with patients’ primary health care providers to achieve optimal and sustainable benefits for most patients. Studies of efficacy and effectiveness involving a variety of service models and settings document survival benefits and improvements in clinical and behavioural outcomes beyond those currently achieved from revascularisation and protective pharmacotherapy. However, secondary prevention interventions are underutilised, which points to the need to tailor programs to reach the majority of patients with CVD. Where such prevention programs are provided locally and can be sustained, they improve the adherence to medical management and thus to the long-term control of disease progression.

1 Summary of 371 cardiac rehabilitation programs in Australia*

Features of programs

No. of programs


Model of care

Education and counselling with supervised exercise

260 (70%)

Education and counselling without supervised exercise

67 (18%)

Exercise only

18 (5%)

Setting

Hospital

190 (51%)

Home

15 (4%)

Community

91 (25%)

Flexible

64 (17%)

Time-limited

267 (72%)

Group-based

288 (78%)

Maintenance offered

125 (34%)

Heart failure management program offered

64 (17%)


* Described in state directories on the Australian Cardiovascular Health and Rehabilitation Association website (http://www.acra.net.au) or available from the National Heart Foundation of Australia by individual state. Model of care information unavailable for 26 programs. Setting information unavailable for 11 programs.

2 Recommendations to improve referral, attendance and completion of cardiac rehabilitation and secondary prevention programs, and continue maintenance of prevention measures

Process

Recommendation


Referral

Include automatic referral in the clinical pathway

Physicians strongly recommend attendance

Link referral to Medicare items (eg, Enhanced Primary Care Program)

Use marketing strategies to increase awareness

Adopt national key performance indicators

Organise coordination of referrals by cardiac rehabilitation staff

Offer flexible programs in a variety of settings

Address barriers to access early, while in hospital

Target women, culturally and linguistically diverse and Indigenous populations


Enrolment/ attendance

Provide patient with an appointment and reconfirm 1–2 weeks prior

Adopt a patient-centred approach and tailor the program accordingly

Actively facilitate peer support

Involve patient carers in the program

Involve cardiologists and general practitioners in planning

Use existing local resources

Provide accessible parking at program centres

Provide dedicated and expanded program funding

Involve Aboriginal and multicultural health workers if appropriate

Develop women-only groups if appropriate

Develop patient resources in languages other than English


Completion

Adopt standard definitions of eligibility, attendance and completion

Set program completion date at outset

Communicate with patients’ health care providers before and after the program

Refer on to community programs where available

Build in a reward system


Maintenance

Support and develop community-based programs

Encourage participation in maintenance programs

Follow up at least once within 12 months

  • Tom G Briffa1
  • Leigh Kinsman2
  • Andrew J Maiorana3,4
  • Robert Zecchin5
  • Julie Redfern6
  • Patricia M Davidson4
  • Glenn Paull7
  • Amanda Nagle8
  • A Robert Denniss9,10

  • 1 School of Population Health, University of Western Australia, Perth, WA.
  • 2 School of Rural Health, Monash University, Bendigo, VIC.
  • 3 Royal Perth Hospital, Perth, WA.
  • 4 Curtin University of Technology, Perth, WA.
  • 5 Sydney West Area Health Service, Sydney, NSW.
  • 6 ANZAC Research Institute, Concord Hospital, Sydney, NSW.
  • 7 St George Hospital, Sydney, NSW.
  • 8 National Heart Foundation of Australia, Newcastle, NSW.
  • 9 University of Western Sydney, Sydney, NSW.
  • 10 Westmead and Blacktown Hospitals, Sydney, NSW.

Correspondence: tom.briffa@uwa.edu.au

Acknowledgements: 

We thank Robyn Clark and Stephen Bunker who were advisory committee members, and Alan Goble, Marian Worcester and the executive management committee of the Australian Cardiovascular Health and Rehabilitation Association for the review of preliminary versions of this manuscript and for their helpful suggestions for improvement.

Competing interests:

None identified.

  • 1. Australian Institute of Health and Welfare. Australia’s health 2008. Canberra: AIHW, 2008. (AIHW Cat. No. AUS 99.) http://www.aihw.gov.au/publications/aus/ah08/ah08.pdf (accessed May 2009).
  • 2. White HD, Willerson JT. We must use the knowledge that we have to treat patients with acute coronary syndromes. Circulation 2004; 109: 698-700.
  • 3. Ades PA. Cardiac rehabilitation and secondary prevention of coronary heart disease. N Engl J Med 2001; 345: 892-902.
  • 4. Wenger N. Current status of cardiac rehabilitation. J Am Coll Cardiol 2008; 51: 1619-1631.
  • 5. Taylor RS, Brown A, Ebrahim S, et al. Exercise-based rehabilitation for patients with coronary heart disease: systematic review and meta-analysis of randomized controlled trials. Am J Med 2004; 116: 682-692.
  • 6. Clark AM, Hartling L, Vandermeer B, McAlister FA. Secondary prevention program for patients with coronary artery disease: a meta-analysis of randomized control trials. Ann Intern Med 2005; 143: 659-672.
  • 7. McAlister FA, Stewart S, Ferrua S, McMurray JJ. Multidisciplinary strategies for the management of heart failure patients at high risk for admission: a systematic review of randomized trials. J Am Coll Cardiol 2004; 44: 810-819.
  • 8. Fidan D, Unal B, Critchley J, Capewell S. Economic analysis of treatments reducing coronary heart disease mortality in England and Wales, 2000–2010. QJM 2007; 100: 277-289.
  • 9. Leon AS, Franklin BA, Costa F, et al. Cardiac rehabilitation and secondary prevention of coronary heart disease. Circulation 2005; 111: 369-376.
  • 10. Scott IA, Lindsay KA, Harden HE. Utilisation of outpatient cardiac rehabilitation in Queensland. Med J Aust 2003; 179: 341-345. <MJA full text>
  • 11. Driscoll A, Worrall-Carter L, McLennan S, et al. Heterogeneity of heart failure management programs in Australia. Eur J Cardiovasc Nurs 2006; 5: 75-82.
  • 12. Redfern JR, Ellis ER, Briffa T, Freedman SB. High-risk factor level and prevalence and low-risk factor knowledge in patients not accessing cardiac rehabilitation after acute coronary syndrome. Med J Aust 2007; 186: 21-25. <MJA full text>
  • 13. Smart N, Marwick TH. Exercise training for heart failure patients: a systematic review of factors that improve patient mortality and morbidity. Am J Med 2004; 116: 693-706.
  • 14. Goble A, Worcester M. Best practice guidelines for cardiac rehabilitation and secondary prevention. Melbourne: Heart Research Centre on behalf of Department of Human Services Victoria, 1999. http://www.health.vic.gov.au/nhpa/downloads/bestpracticecardiacrehab.pdf (accessed May 2009).
  • 15. Ades P. Individualized preventive care in cardiac rehabilitation. J Cardiopulm Rehabil Prev 2007; 27: 130-134.
  • 16. National Heart Foundation of Australia and Australian Cardiac Rehabilitation Association. Recommended framework for cardiac rehabilitation ‘04. Canberra: National Heart Foundation, 2006. http://www.heartfoundation.org.au/SiteCollectionDocuments/cr%2004%20rec.pdf (accessed May 2009).
  • 17. Dafoe W, Arthur H, Stokes H, et al. Universal access: but when? Treating the right patient at the right time: access to cardiac rehabilitation. Can J Cardiol 2006; 22: 905-911.
  • 18. Clark A, Hartling L, Vandermeer B, McAlister F. Secondary prevention programmes for coronary heart disease: a meta-regression showing the merits of shorter, generalist, primary care-based interventions. Eur J Cardiovasc Prev Rehabil 2007; 14: 538-546.
  • 19. Haskell WL, Alderman EL, Fair JM, et al. Effects of intensive multiple risk factor reduction on coronary atherosclerosis and clinical cardiac events in men and women with coronary artery disease. The Stanford Coronary Risk Intervention Project (SCRIP). Circulation 1994; 89: 975-990.
  • 20. DeBusk RF, Miller NH, Superko HR, et al. A case-management system for coronary risk factor modification after acute myocardial infarction. Ann Intern Med 1994; 120: 721-729.
  • 21. Vale M, Jelinek M, Best JD, Santamaria JD. Coaching patients with coronary heart disease to achieve the target cholesterol: a method to bridge the gap between evidence-based medicine and the “real world” — randomized controlled trial. J Clin Epidemiol 2002; 55: 245-252.
  • 22. Jolly K, Lip GYH, Taylor RS, et al. The Birmingham Rehabilitation Uptake Maximisation study (BRUM): a randomised controlled trial comparing home-based with centre-based cardiac rehabilitation. Heart 2009; 95: 36-42.
  • 23. Redfern J, Ellis E, Briffa T, Freedman SB. Patient-centered modular secondary prevention following acute coronary syndrome: a randomized controlled trial. J Cardiopulm Rehabil Prev 2008; 28: 107-115.
  • 24. Balady GJ, Williams MA, Ades PA, et al. Core components of cardiac rehabilitation/secondary prevention programs: 2007 update: a scientific statement from the American Heart Association Exercise, Cardiac Rehabilitation, and Prevention Committee, the Council on Clinical Cardiology; the Councils on Cardiovascular Nursing, Epidemiology and Prevention, and Nutrition, Physical Activity, and Metabolism; and the American Association of Cardiovascular and Pulmonary Rehabilitation. Circulation 2007; 115: 2675-2682.
  • 25. Daly J, Sindone AP, Thompson DR, et al. Barriers to participation in and adherence to cardiac rehabilitation programs: a critical literature review. Prog Cardiovasc Nurs 2002; 17: 8-17.
  • 26. Dollard J, Smith J, Thompson D, Stewart S. Broadening the reach of cardiac rehabilitation to rural and remote Australia. Eur J Cardiovasc Nurs 2004; 3: 27-42.
  • 27. Higgins RO, Murphy BM, Goble AJ, et al. Cardiac rehabilitation program attendance after coronary artery bypass surgery: overcoming the barriers. Med J Aust 2008; 188: 712-714. <MJA full text>
  • 28. National Heart Foundation of Australia and the Cardiac Society of Australia and New Zealand (Chronic Heart Failure Guidelines Expert Writing Panel). Guidelines for the prevention, detection and management of chronic heart failure in Australia, 2006. Canberra: National Heart Foundation, 2006. http://www.heartfoundation.org.au/SiteCollectionDocuments/CHF%202006 %20Guidelines%20NHFA-CSANZ%20WEB.pdf (accessed May 2009).
  • 29. Davidson P, MacDonald P, Paull G, et al. Diuretic therapy in chronic heart failure: implications for heart failure nurse specialists. Aust Crit Care 2003; 16: 59-69.
  • 30. Yallop JJ, McAvoy BR, Croucher JL, et al, on behalf of the CHAT Study Group. Primary health care research — essential but disadvantaged. Med J Aust 2006; 185: 118-120. <MJA full text>
  • 31. Pina IL, Apstein CS, Balady GJ, et al. Exercise and heart failure: a statement from the American Heart Association Committee on exercise, rehabilitation, and prevention. Circulation 2003; 107: 1210-1225.
  • 32. Haykowsky M, Liang Y, Pechter D, Jones L. A meta-analysis of the effect of exercise training on left ventricular remodelling in heart failure patients: the benefit depends on the type of training performed. J Am Coll Cardiol 2007; 49: 2329-2336.

Author

remove_circle_outline Delete Author
add_circle_outline Add Author

Comment
Do you have any competing interests to declare? *

I/we agree to assign copyright to the Medical Journal of Australia and agree to the Conditions of publication *
I/we agree to the Terms of use of the Medical Journal of Australia *
Email me when people comment on this article

Responses are now closed for this article.